Riskpilot← Back to searchSign inGet full accessFavoptic Eye care AB
ABActiveOrg 5565758983Gudmundvägen 7Other human health activities n.e.c. · NACE 8699Est. 19995-9 employees
Revenue 2024
SEK 638K
+6% vs 2023
EBITDA margin
-123.7%
-81% vs 2023
Equity ratio
-174.2%
Financial strength
Net profit 2024
SEK -807K
-82% vs 2023
| Revenue | SEK 638K | +6% |
| EBITDA | SEK -789K | -81% |
| Net profit | SEK -807K | -82% |
| Total assets | SEK 1,6M | -17% |
| Equity | SEK -2,7M | -42% |
| Employees | — | — |
Legal name
Favoptic Eye care AB
Org number
5565758983
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
17 september 1999
Share capital
SEK 100 000
Employees
5-9
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av Eriksson, Carl Erik Eriksson, Harriet Monica
Company purpose
Bolaget ska bedriva medicinsk konsultverksamhet, service och supportverksamhet samt handel med glasögon och därmed förenlig verksamhet.
Address
Gudmundvägen 7
Phone
+4687530999
Email
carleriksson@mac.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 428 | 524 | 598 | 603 | 638 |
| Staff expenses | — | — | — | −861 | −1 242 |
| EBITDA | −678 | −1 035 | −511 | −436 | −789 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −678 | −1 035 | −511 | −436 | −789 |
| Net financials | −10 | −21 | −8 | −7 | −18 |
| Profit before tax | 12 | −1 056 | −519 | −443 | −807 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | 12 | −1 056 | −519 | −443 | −807 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 896 | 2 937 | 2 226 | 1 876 | 1 557 |
| Equity | 112 | −944 | −1 463 | −1 906 | −2 713 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 3 784 | 3 881 | 3 689 | 3 782 | 4 270 |
| Total debt | 3 784 | 3 881 | 3 689 | 3 782 | 4 270 |
EBITDA margin
-123.7%
This company
15.8%
Market median
-883% vs market
20202024
Equity ratio
-174.2%
This company
38.2%
Market median
-556% vs market
20202024
Return on equity
-80659900.0%
This company
18.4%
Market median
-438369122% vs market
20202024
Net profit margin
-126.4%
This company
8.1%
Market median
-1660% vs market
20202024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Favoptic Eye care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Tilander | Audit | 0 companies |
| Harriet Monica Eriksson | Deputy Board Member | 0 companies |
| Carl Erik Eriksson | Board of Directors | 0 companies |